Natera Inc

Natera Inc

NTRA

Market Cap$21.54B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Natera IncNatera Inc-112--15%12.40.2

Earnings Call Q1 2025

May 8, 2025 - AI Summary

Strong Revenue Growth: Natera reported Q1 2025 revenue of $502 million, a 37% year-over-year increase from $368 million in Q1 2024. This growth is driven by a remarkable uptick in volume, with 855,000 units processed this quarter, reflecting exceptional performance across all segments, particularly women's health and oncology.
Record Volume and ASP Improvement: Signatera clinical volumes grew by 52% year-over-year, with a significant sequential increase of 16,500 units compared to Q4 2024. Average selling prices (ASP) for Signatera surpassed $1,100, benefiting from improved reimbursement coverage, particularly in Medicare Advantage.
Revised Revenue Guidance: The company raised its 2025 revenue guidance by $70 million at the midpoint, projecting revenues to be in the range of $1.94 billion to $2.02 billion. This reflects a strong outlook of approximately 26% revenue growth year-over-year, excluding true-ups, indicating sustained market demand and operational efficiencies.

Exclusive for Stockcircle Pro members

Sign upSign Up
$195.00

Target Price by Analysts

21.4% upsideNatera Target Price DetailsTarget Price
$-160.91

Current Fair Value

200.1% downside

Overvalued by 200.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$21.54 Billion
Enterprise Value$20.81 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.53
Beta1.79
Outstanding Shares134,750,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-112
PEG11419.79
Price to Sales12.36
Price to Book Ratio17.85
Enterprise Value to Revenue11.36
Enterprise Value to EBIT-96.22
Enterprise Value to Net Income-110
Total Debt to Enterprise0.01
Debt to Equity0.2

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Natera Inc

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operat...